Case discussions on Hypothyroidism and SCH: Dr. Balaji C & Dr. Nandakumar
M3 India Newsdesk Nov 13, 2019
Dr. Balaji Chinnaswami and Dr. Nandakumar R, with the help of case discussions, provide quick diagnosis and treatment guides for hypothyroidism and subclinical hypothyroidism (SCH).
Key practice points
- All babies should be screened for hypothyroidism. Low T4 and high TSH suggest primary congenital hypothyroidism. On follow-up visits, high TSH in the presence of normal FT4 suggests chronic poor adherence. Rechecking for permanency can be done at 3 years of age. At this time, a nuclear scan can also be done if not done before.
- Females, usually young or middle-aged with clinical features and strong family history gives clues for hypothyroidism. Low free T3, free low T4, and elevated TSH reveal primary hypothyroidism.
- Elevated TSH value with normal free T4 and free T3 reports is suggestive of subclinical hypothyroidism. Subclinical hypothyroidism with positive antibody needs to be treated and followed up because of the chance of progression to overt hypothyroidism.
Case 1- Primary congenital hypothyroidism
A full-term, 2.5 kg, newborn (female) is taken for a heel prick test. TSH was 38 mIU/L (serum units) done on day 3 of life.
Science behind diagnosis
Screening for hypothyroidism is done by TSH in cord blood at birth or heel prick/venous blood sample at 2 to 5 days of life.
- If screening TSH >20 mIU/L of serum units, do a confirmatory venous blood testing
- If in confirmatory venous sample, TSH is >20 mIU/L in first 2 weeks of life or TSH is >10 mIU/L after two weeks of age with low T4 (FT4 <1.17 ng/dl), it is suggestive of primary congenital hypothyroidism
In this case since screening TSH >20 mIU/L, confirmatory venous sample was sent.
Confirmatory venous sample results: TSH- 80 mIU/L and FT4- 0.15 ng/dl. Low T4 and high TSH suggest primary congenital hypothyroidism.
Note: TSH is represented in serum units. If the lab gives results in whole blood units, convert 'whole blood units x 2.2 = serum units'.
Rx
- Tab. Levothyroxine
- Dose: 25 µg (10-15 µg/kg)
- Frequency: Once a day
- Duration: Not to be stopped without doctor's advice
Further investigations
- Thyroid ultrasound
- Thyroid nuclear imaging (Technetium 99 scan)
Note:
- Both investigations are done to look for agenesis of thyroid which needs life-long thyroxine replacement.
- Treatment should not be delayed if there is delay in getting the imaging done.
- If not done initially, nuclear scan can be done by 3 years of age.
Advice to give to parents
- Taking daily treatment is the key to prevent neurological damage. Discuss with parents the importance of compliance and follow up.
- Crush tablet in small quantity of breast milk. Do not add tablet to bottle feed.
- Patient should be brought every 3 to 6 months follow up testing of TSH.
Follow-up visit with patient at 8 months: The girl is on 25 µg/day of Tab. Levothyroxine. Her growth appears normal and she has attained developmental milestones appropriately. On follow up testing, FT4 is 1.6 ng/dl (normal 1.1-2.1); TSH is 9.5 mIU/L (normal 0.5-5.5).
Science behind diagnosis
- High TSH in the presence of normal FT4 suggest chronic poor adherence
- TSH is elevated as thyroxine medications were not taken for a long period of time
- FT4 is normal as the girl has been taking multiple doses just before sampling
Treatment and further advice
- Continue the same dosage of 25 µg/day of thyroxine tablet.
- Stress the importance of taking medications daily.
Checking for permanency of condition & advice to give to parents
Parents of the child inquired if thyroxine needs to be given life-long; if not until what period should it be continued?
Rechecking for permanency can be done at 3 years of age by stopping medication for 4 to 6 weeks and doing a thyroid profile. If thyroid profile is suggestive of hypothyroidism, treatment needs to be lifelong. Also, if the nuclear scan has not been done before, it can be done at the time of stopping medications.
Case 2- Hypothyroidism in adults
A 36-year old female presents with complaints of weight gain of 3 kgs over 6 months, menstrual disturbance for 5 months, and fatigue for 5 months. She mentioned that her elder sister is also taking treatment for thyroid disorder.
Science behind diagnosis
Females, usually young or middle-aged with clinical features and strong family history gives clues for hypothyroidism.
- Ask for other symptoms like cold intolerance, constipation, increased sleep, alopoecia etc.
- Other signs like dry skin, pedal oedema can be elicited
- The most common aetiology is autoimmune
Investigations
- Thyroid function test- Free T3- low , free T4- low, TSH- elevated (>100 mIU/l). Her blood reports reveal primary hypothyroidism
- USG neck reveal thyroiditis
- Complete blood count reveals anaemia (Haemoglobin- 9.5 g/dl)
Management: Levothyroxine dosing guidelines for adults
- Non-pregnant patients: 1.6 mcg per kg per day initial dosage
- Older patients; patients with known or suspected cardiac disease: 25 or 50 mcg daily starting dosage; increase by 25 mcg every 3 to 4 weeks until full replacement dosage reached
Rx
- Tab. Levothyroxine
- Dose: 100 mcg
- Frequency: Once daily, early in the morning (6 am)
- Duration: 6 weeks
- Tab. Ferrous ascorbate (Hematinic for anaemia)
- Dose: 100 mg
- Frequency: Once daily, 2 hours after a meal
- Duration: 1 month
Advice to give to patient
- To follow medicines regularly, motivate the patient to take levothyroxine early in the morning. If a dose is missed, it can be taken any time of the day without skipping.
- Avoid vegetables like broccoli, cabbage, cauliflower. Minimise gluten-containing diet like wheat, barley, rye, and other grains.
- Avoid alternate treatments as there are no proven benefits with native medicines.
- Regularly follow up with doctor, as recommended, as it is needed to decrease or increase dose or even to stop levothyroxine.
Case 3- Subclinical hypothyroidism (SCH)
A 56-year-old man presents with his master health check up reports that was done recently. He is a known hypertensive on medications. He doesn’t have any other significant complaints.
Science behind diagnosis
Elevated TSH value with normal free T4 and free T3 reports is suggestive of subclinical hypothyroidism.
- Patients should be asked for associated symptoms if any
- Treatment should be based on thyroid function test, clinical features and thyroid antibody assay
Subclinical hypothyroidism with positive antibody needs to be treated and followed up because of the chance of progression to overt hypothyroidism.
Investigations
- Thyroid function test: F T3 and FT4 are within normal range, TSH- 8.2 mIU/L (elevated)
- Anti-TPO (thyroid peroxidise) antibody >100 IU/ml (elevated ), TgAb (thyroglobulin antibody)- 45 IU/ml (elevated)
- USG neck is normal
Management: Levothyroxine dosing guidelines for subclinical hypothyroidism in adults
- Subclinical hypothyroidism without symptoms (antibody positive)
- TSH <10 mIU/L: 50 mcg daily; increase by 25 mcg daily every six weeks until TSH = 0.35 to 5.5 mIU/L
- TSH ≥10 mIU/L: 1.6 mcg per kg per day
- Subclinical hypothyroidism with symptoms
- TSH >5.5 mIU/L, irrespective of antibody assay; treatment has to be started with 1.6 mcg per kg per day; review after 6 weeks
Rx
- Tab. Levothyroxine (subclinical hypothyroidism, no symptoms by antibody +)
- Dose: 50 mcg
- Frequency: Once daily, early in the morning (6 am)
- Duration: 6 weeks
- Continue anti-hypertensive medication
Advice to give to patients
- To follow medicines regularly, motivate the patient to take levothyroxine early in the morning. If a dose is missed, it can be taken any time of the day without skipping.
- Avoid vegetables like broccoli, cabbage, cauliflower. Minimise gluten-containing diet like wheat, barley, rye, and other grains.
- Avoid alternate treatments as there are no proven benefits with native medicines.
- Regularly follow up as recommended by the doctor to check if it is needed to decrease or increase dose or even to stop levothyroxine.
Disclaimer- The views and opinions expressed in this article are those of the author's and do not necessarily reflect the official policy or position of M3 India.
The authors, Dr. Balaji Chinnaswami and Dr. Nandakumar R are professors of Paediatrics and Medicine at a reputed medical college in Chennai.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries